This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Furthermore, by fostering connectivity and automating tasks, DHTs reduce administrative burdens, accelerate recruitment, and improve overall trial transparency, ultimately contributing to faster and more reliable drugdevelopment. In a recent review paper appeared on Nature , Mittermaier et al. in 2010 to 11.4%
For the pharmacovigilance space, for example, this automation will begin as a tool for recommendations, suggestions or options for potential safety reports, but it will not fully replace human efforts particularly as there are concerns around data output consistency. Dave Latshaw, CEO at BioPhy 1.
Point-of-Care Diagnostics: Companies developing point-of-care diagnostic tests to assess wound severity and monitor healing progress are also attracting VC interest. Recent Examples of VC Investment in Wound Care: Corryn Biotechnologies: This UK-based startup raised £550,000 in seed funding to develop a novel wound dressing technology.
It would be incredibly valuable, for instance, to be able to run a structured query against a collection of images sitting in BLOB storage, and pull out every example showing a concerning mass in a particular part of the patient’s body that’s consistent with the others in order to determine the best course for treatment.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content